{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:35Z","timestamp":1787772215409,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R18HS028562"],"award-info":[{"award-number":["R18HS028562"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inappropriate prescribing of Direct Oral Anticoagulants (DOACs) is a leading cause of adverse outcomes. Electronic health record (EHR)-based notification strategies may support evidence-based prescribing and reduce adverse events. Engaging clinical pharmacists (vs. prescribers) through EHR-based notifications that review inappropriate DOAC prescribing may be an effective strategy for ensuring evidence-based medication prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a pragmatic, single-center, parallel-group, randomized implementation trial using notifications (asynchronous EHR-based notifications) to prompt correction of inappropriate DOAC prescriptions that had arisen after the initial prescription of the DOAC (e.g., due to changes in patient condition). Notifications were sent for adult ambulatory patients with DOAC prescriptions not adhering to the package insert instructions or having significant drug-drug interactions. Notifications directed either to the prescribing clinician or to the clinical anticoagulation pharmacist, randomized at the prescriber level. The primary outcome was the proportion of notifications adopting any prescription change within 7 days. Moderator analyses examined the influence of prescriber, patient, and prescription characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From May 2023 to December 2024, 388 notifications for potentially inappropriate DOAC prescriptions among 183 prescribers were analyzed. Overall, 23.2% of notifications led to a prescription change within 7 days, 26% among prescriber-directed and 21% among pharmacist-directed notifications (p\u2009=\u20090.36). Nearly all (97.8%) changes made were clinically appropriate changes aligned with notification recommendations. Subgroup and moderator analyses showed that pharmacists made more changes than prescribers when errors were further from dosing cutoffs and managed cases with polypharmacy or complex thresholds more consistently. Clinical pharmacists spent an average of 7.9 min per notification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prescribers and clinical pharmacists both responded similarly and consistently to correct inappropriate DOAC prescriptions in response to EHR asynchronous notifications. While pharmacists did not outperform prescribers overall, they demonstrated more nuanced application of medication prescribing guidelines in complex cases. Engaging clinical pharmacists directly may be an efficient implementation strategy for addressing medication prescribing issues. Optimal EHR-based implementation strategies for complex prescribing guidelines should consider both workflow integration and recipient expertise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>(ClinicalTrials.gov: NCT05351749).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13012-025-01478-9","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:26:44Z","timestamp":1765805204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementing prescriber-pharmacist collaboration to improve evidence-based medication prescribing using asynchronous, non-interruptive electronic health record notifications"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-8440","authenticated-orcid":false,"given":"Geoffrey D.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Youn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael SM","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Errickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Jacob","family":"Seagull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna N","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1478_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"key":"1478_CR2","doi-asserted-by":"publisher","first-page":"e007971","DOI":"10.1161\/CIRCOUTCOMES.121.007971","volume":"14","author":"X-L Zhang","year":"2021","unstructured":"Zhang X-L, Zhang X, Wang T-Y, Wang H, Chen Z, Xu B, et al. Off-label under- and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2021;14:e007971.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1478_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/imj.16280","volume":"54","author":"CL Snoswell","year":"2024","unstructured":"Snoswell CL, De Guzman KR, Barras M. Advanced-scope pharmacist roles in medical outpatient clinics: a cost-consequence analysis. Intern Med J. 2024;54:404\u201313.","journal-title":"Intern Med J"},{"key":"1478_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jep.13209","volume":"26","author":"RA Al-Qudah","year":"2020","unstructured":"Al-Qudah RA, Al-Badriyeh D, Al-Ali FM, Altawalbeh SM, Basheti IA. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients. J Eval Clin Pract. 2020;26:115\u201324.","journal-title":"J Eval Clin Pract"},{"key":"1478_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijmedinf.2017.05.011","volume":"105","author":"N Page","year":"2017","unstructured":"Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inform. 2017;105:22\u201330.","journal-title":"Int J Med Inform"},{"key":"1478_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.2021.13844","volume":"326","author":"DS Budnitz","year":"2021","unstructured":"Budnitz DS, Shehab N, Lovegrove MC, Geller AI, Lind JN, Pollock DA. Us emergency department visits attributed to medication harms, 2017\u20132019. JAMA. 2021;326:1299\u2013309.","journal-title":"JAMA"},{"key":"1478_CR7","doi-asserted-by":"publisher","first-page":"e014108","DOI":"10.1161\/JAHA.119.014108","volume":"9","author":"S Sanghai","year":"2020","unstructured":"Sanghai S, Wong C, Wang Z, Clive P, Tran W, Waring M, et al. Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF study. J Am Heart Assoc. 2020;9:e014108.","journal-title":"J Am Heart Assoc"},{"key":"1478_CR8","doi-asserted-by":"publisher","first-page":"581293","DOI":"10.3389\/fphar.2021.581293","volume":"12","author":"N-N Shen","year":"2021","unstructured":"Shen N-N, Zhang C, Hang Y, Li Z, Kong L-C, Wang N, et al. Real-world prevalence of direct oral anticoagulant off-label doses in atrial fibrillation: an epidemiological meta-analysis. Front Pharmacol. 2021;12:581293.","journal-title":"Front Pharmacol"},{"key":"1478_CR9","doi-asserted-by":"crossref","unstructured":"Herron GC, DeCamillo D, Kong X, Haymart B, Kaatz S, Ellsworth S, et al. Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems. Thromb Haemost. 2025;25:278\u201385.","DOI":"10.1055\/a-2365-8681"},{"key":"1478_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13012-023-01273-4","volume":"18","author":"SN Smith","year":"2023","unstructured":"Smith SN, Lanham M, Seagull FJ, Dorsch M, Errickson J, Barnes GD. Implementing pharmacist-prescriber collaboration to improve evidence-based anticoagulant use: a randomized trial. Implement Sci. 2023;18:16.","journal-title":"Implement Sci"},{"key":"1478_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2019.00064","volume":"7","author":"RE Glasgow","year":"2019","unstructured":"Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM planning and evaluation framework: Adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:1\u20139.","journal-title":"Front Public Health"},{"key":"1478_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"1478_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/ajhp\/zxad100","volume":"80","author":"A Massmann","year":"2023","unstructured":"Massmann A, Petry NJ. Impact of transitioning to an active, noninterruptive CYP2C19\/proton pump inhibitor alert on prescribing patterns. Am J Health Syst Pharm. 2023;80:1004\u20139.","journal-title":"Am J Health Syst Pharm"},{"key":"1478_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/amiajnl-2010-000039","volume":"18","author":"HM Seidling","year":"2011","unstructured":"Seidling HM, Phansalkar S, Seger DL, Paterno MD, Shaykevich S, Haefeli WE, et al. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc. 2011;18:479\u201384.","journal-title":"J Am Med Inform Assoc"},{"key":"1478_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cmpb.2013.02.006","volume":"111","author":"M-L Yeh","year":"2013","unstructured":"Yeh M-L, Chang Y-J, Wang P-Y, Li Y-CJ, Hsu C-Y. Physicians\u2019 responses to computerized drug-drug interaction alerts for outpatients. Comput Methods Programs Biomed. 2013;111:17\u201325.","journal-title":"Comput Methods Programs Biomed"},{"key":"1478_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/jamia\/ocz025","volume":"26","author":"CB Monsen","year":"2019","unstructured":"Monsen CB, Liao JM, Gaster B, Flynn KJ, Payne TH. The effect of medication cost transparency alerts on prescriber behavior. J Am Med Inform Assoc. 2019;26:920\u20137.","journal-title":"J Am Med Inform Assoc"},{"key":"1478_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/amiajnl-2013-001813","volume":"21","author":"KC Nanji","year":"2014","unstructured":"Nanji KC, Slight SP, Seger DL, Cho I, Fiskio JM, Redden LM, et al. Overrides of medication-related clinical decision support alerts in outpatients. J Am Med Inform Assoc. 2014;21:487\u201391.","journal-title":"J Am Med Inform Assoc"},{"key":"1478_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/archinternmed.2008.551","volume":"169","author":"T Isaac","year":"2009","unstructured":"Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med. 2009;169:305\u201311.","journal-title":"Arch Intern Med"},{"key":"1478_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00228-021-03212-y","volume":"78","author":"A Al Rowily","year":"2022","unstructured":"Al Rowily A, Jalal Z, Price MJ, Abutaleb MH, Almodiaemgh H, Al Ammari M, et al. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2022;78:623\u201345.","journal-title":"Eur J Clin Pharmacol"},{"key":"1478_CR20","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1001\/jama.2021.15319","volume":"326","author":"R Brignardello-Petersen","year":"2021","unstructured":"Brignardello-Petersen R, Carrasco-Labra A, Guyatt GH. How to interpret and use a clinical practice guideline or recommendation: users\u2019 guides to the medical literature. JAMA. 2021;326:1516\u201323.","journal-title":"JAMA"},{"key":"1478_CR21","doi-asserted-by":"publisher","first-page":"e035859","DOI":"10.1161\/JAHA.124.035859","volume":"13","author":"GD Barnes","year":"2024","unstructured":"Barnes GD, Chen C, Holleman R, Errickson J, Seagull FJ, Dorsch MP, et al. Pharmacist use of a population management dashboard for safe anticoagulant prescribing: evaluation of a nationwide implementation effort. J Am Heart Assoc. 2024;13:e035859.","journal-title":"J Am Heart Assoc"},{"key":"1478_CR22","first-page":"488","volume":"10","author":"B Kefale","year":"2024","unstructured":"Kefale B, Peterson GM, Mirkazemi C, Bezabhe WM. The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis. Eur Heart J. 2024;10:488\u2013506.","journal-title":"Eur Heart J"},{"key":"1478_CR23","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.tru.2023.100158","volume":"14","author":"V Silvari","year":"2024","unstructured":"Silvari V, Crowley EK, Carey M, Robertson S, McCarthy S. Value of hospital anticoagulation stewardship programme: a systematic review. Thrombosis Update. 2024;14:100158.","journal-title":"Thrombosis Update"},{"key":"1478_CR24","doi-asserted-by":"publisher","first-page":"e12803","DOI":"10.1002\/rth2.12803","volume":"6","author":"FJ Seagull","year":"2022","unstructured":"Seagull FJ, Lanham MS, Pomorski M, Callahan M, Jones EK, Barnes GD. Implementing evidence-based anticoagulant prescribing: User-centered design findings and recommendations. Res Pract Thromb Haemost. 2022;6:e12803.","journal-title":"Res Pract Thromb Haemost"},{"key":"1478_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/jamia\/ocab009","volume":"28","author":"Q Yan","year":"2021","unstructured":"Yan Q, Jiang Z, Harbin Z, Tolbert PH, Davies MG. Exploring the relationship between electronic health records and provider burnout: a systematic review. J Am Med Inform Assoc. 2021;28:1009\u201321.","journal-title":"J Am Med Inform Assoc"},{"key":"1478_CR26","first-page":"481","volume":"289","author":"R Muhiyaddin","year":"2022","unstructured":"Muhiyaddin R, Elfadl A, Mohamed E, Shah Z, Alam T, Abd-Alrazaq A, et al. Electronic Health Records and Physician Burnout: A Scoping Review. Stud Health Technol Inform. 2022;289:481\u20134.","journal-title":"Stud Health Technol Inform"},{"key":"1478_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/jamia\/ocz220","volume":"27","author":"J Adler-Milstein","year":"2020","unstructured":"Adler-Milstein J, Zhao W, Willard-Grace R, Knox M, Grumbach K. Electronic health records and burnout: time spent on the electronic health record after hours and message volume associated with exhaustion but not with cynicism among primary care clinicians. J Am Med Inform Assoc. 2020;27:531\u20138.","journal-title":"J Am Med Inform Assoc"}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-025-01478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13012-025-01478-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-025-01478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:03:32Z","timestamp":1771329812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13012-025-01478-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/s13012-025-01478-9","relation":{},"ISSN":["1748-5908"],"issn-type":[{"value":"1748-5908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study reviewed by the University of Michigan Medical Institutional Review Board and approved (HUM00207165) with a waiver of informed consent for the prescriber and patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No person\u2019s individual data is included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GDB \u2013 consulting for Pfizer, Bristol-Myers Squibb, Janssen, Bayer, AstraZeneca, Sanofi, Anthos, Boston.Scientific, Novartis; grant funding from Boston Scientific; Board of Directors for the Anticoagulation Forum.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}